HMC Marks World Hemophilia Day with Awareness Events

Doha, May 28 (QNA) - In recognition of World Hemophilia Day, Hamad Medical Corporation (HMC) in collaboration with the Friends of Hemophilia Society recently hosted a series of awareness and education events for HMC staff, as well as for hemophilia patients and their families. This year, the theme for World Hemophilia Day is "Access for All: Prevention of bleeds as the global standard of care".
World Hemophilia Day provides an ideal opportunity to educate patients and healthcare professionals about the condition, which is an important part of building community support for individuals living with bleeding disorders.
Dr. Ahmed Abdulaziz Abdelbari, Clinical Pharmacist at Hamad General Hospital, said the event lectures focused on strategies to safely perform surgeries on patients with blood disorders. He noted that Qatars health system offers state-of-the-art healthcare facilities and equipment, as well as highly experienced care teams, both of which are essential for better health outcomes for patients with hemophilia.
"Hemophilia can greatly affect the quality of life of patients and their families. Males are generally more likely to have hemophilia than females. Hemophilia is often linked to genes inherited from the mother, a genetic mutation, pregnancy, or malignant diseases such as cancer," said Dr. Abdelbari.
Hemophilia is a rare genetic disorder that results from the deficiency or absence of one of the clotting factors in the blood (proteins). This can cause bleeding for a longer time than normal following injury.
The treatment of hemophilia generally aims at preventing the complications of hemorrhages, especially brain and joints hemorrhages, by administering genetically engineered blood-clotting factor medications intravenously and using other medications that help reduce bleeding and prevent disabilities. (QNA)